Health & Personal Care
HIGH
FDA DRUG
Novartis/Sandoz Otic Suspension Recalled for Temperature Abuse (D-0626-2025)
Novartis Manufacturing NV and Sandoz Inc recall ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension after temperature abuse. The recall affects one consignee in California. Consumers and health care providers should stop using the product immediately and follow guidance from Sandoz or a healthcare provider.
CIPROFLOXACIN AND DEXAMETHASONE
Temperature Abuse